Presentation is loading. Please wait.

Presentation is loading. Please wait.

Everolimus Drug-Eluting Stents Are Associated With Improved Outcomes for the Treatment of Infrainguinal Bypass Graft Stenoses  Caitlin W. Hicks, MD, MS,

Similar presentations


Presentation on theme: "Everolimus Drug-Eluting Stents Are Associated With Improved Outcomes for the Treatment of Infrainguinal Bypass Graft Stenoses  Caitlin W. Hicks, MD, MS,"— Presentation transcript:

1 Everolimus Drug-Eluting Stents Are Associated With Improved Outcomes for the Treatment of Infrainguinal Bypass Graft Stenoses  Caitlin W. Hicks, MD, MS, Joseph K. Canner, MHS, Ying W. Lum, MD, MPH, Bruce A. Perler, MD, MBA, James H. Black, MD, Christopher J. Abularrage, MD  Journal of Vascular Surgery  Volume 68, Issue 3, Pages e67-e68 (September 2018) DOI: /j.jvs Copyright © Terms and Conditions

2 Fig Based on Kaplan-Meier curve analysis, primary patency of bypass graft stenoses was significantly better for patients treated with everolimus drug-eluting stent (DES) compared with percutaneous cutting balloon (PCB) or plain old balloon angioplasty (POBA). Journal of Vascular Surgery  , e67-e68DOI: ( /j.jvs ) Copyright © Terms and Conditions


Download ppt "Everolimus Drug-Eluting Stents Are Associated With Improved Outcomes for the Treatment of Infrainguinal Bypass Graft Stenoses  Caitlin W. Hicks, MD, MS,"

Similar presentations


Ads by Google